TY - JOUR T1 - Cardiac magnetic resonance imaging in pulmonary arterial hypertension JF - European Respiratory Review JO - EUROPEAN RESPIRATORY REVIEW SP - 526 LP - 534 DO - 10.1183/09059180.00006313 VL - 22 IS - 130 AU - Andrew J. Peacock AU - Anton Vonk Noordegraaf Y1 - 2013/12/01 UR - http://err.ersjournals.com/content/22/130/526.abstract N2 - Cardiac magnetic resonance imaging (CMRI) provides accurate information about right ventricular (RV) mass, RV volumes and other markers of RV function. CMRI is proving to be a particularly useful tool in pulmonary arterial hypertension (PAH), as measures of RV function have been shown to be prognostic of long-term outcomes in this disease. Changes in RV function can also provide important information about a patient's disease course and response to treatment. As CMRI is noninvasive it can be used to regularly monitor patients with PAH, which is an important advantage over invasive right heart catheterisation. This review will explore the use of CMRI in the context of existing monitoring tools for PAH and will explore the forthcoming developments that are likely to be important in the future monitoring of patients with PAH. ER -